Ben joined Imperial College Health Partners as Health Research Senior Manager in 2022. Prior to this, Ben was Operations Manager of the Future Vaccine Manufacturing Research Hub at Imperial College London, where he managed a clinical trial of an innovative RNA Covid-19 vaccine candidate in Uganda. He was also previously the Research Coordinator to a large research group at Imperial active in regenerative medicine, nanomedicine, tissue engineering, chemistry, and biology. Ben was a postdoctoral researcher and group leader in Berlin, Germany, active in biomaterials research, following his PhD in Chemistry from the University of North Carolina.